News about Drug Discovery & Development

DST Grants INR 13.69 Cr to GITAM for Drug Discovery Centre

The grant, conferred through the Promotion of University Research and Scientific Excellence (PURSE) program, will support the procurement of new equipment, research costs, manpower, conduct of workshops/summer schools etc.

Drug Discovery & Development | 16/10/2023 | By Manvi |  820

Shilpa Medicare Launches ORAAL for the Treatment of Oral Mucositis

ORAAL, a substantial advancement in Oral Mucositis management, has been accepted and approved by the Indian Dental Association.

Drug Discovery & Development | 16/10/2023 | By Manvi |  1211

Fujitsu and RIKEN Develop AI Drug Discovery Technology Utilizing Generative AI to Predict Structural Changes in Proteins

Fujitsu Limited and the HPC- and AI-driven Drug Development Platform Division of the RIKEN Center for Computational Science announced that they have developed an AI drug discovery technology that can predict structural changes of proteins from electron microscope images as a 3D density map in wide range by utilizing generative AI in January 2023.

Drug Discovery & Development | 11/10/2023 | By Manvi |  691

Strides Receives Tentative USFDA Approval for Dolutegravir / Lamivudine / Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides' qualification to all major markets and donor programs including Global Fund and South Africa.

Drug Discovery & Development | 19/09/2023 | By Manvi |  479

Zydus Gets Final Approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day.

Drug Discovery & Development | 19/09/2023 | By Manvi |  699

Strides Pharma Gets USFDA Tentative Nod for Generic HIV Treatment Drug

Strides Pharma Science Ltd said its wholly-owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received tentative approval from the US health regulator for generic Dolutegravir tablets used in the treatment of HIV.

Drug Discovery & Development | 15/09/2023 | By Manvi |  560

Sun Pharma and Pharmazz Enter into Licensing Agreement for Introducing Tyvalzi in India

As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi™ (Sovateltide). Pharmazz will be entitled to upfront and milestone payments, including royalties.

Drug Discovery & Development | 15/09/2023 | By Manvi |  1469

Gufic Biosciences Ltd Receives TGA Australia and ANVISA Brazil Approval for Parecoxib 40mg Injection

Gufic has been persistently committed to saving and improving lives of patients across the globe with its continuous efforts through the international regulatory agencies to bring novel molecules for the mankind.

Drug Discovery & Development | 12/09/2023 | By Manvi |  872

Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

Lupin's Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, is currently the only generic product available that is therapeutically equivalent to Spiriva® HandiHaler® (Tiotropium Bromide Inhalation Powder), 18 mcg/capsule by Boehringer Ingelheim Pharmaceuticals, Inc.

Drug Discovery & Development | 08/09/2023 | By Manvi |  475

DCGI Issues Alert Against Antacid Digene Gel, Abbott Initiates Voluntary Recall

The company announced that it had withdrawn all its batches that were being manufactured at its Goa facility following a complaint from a customer that the liquid in the bottle had turned white, tasted bitter, and had a pungent smell when they bought it

Drug Discovery & Development | 07/09/2023 | By Manvi |  1464